California Federal Judge Allows Antitrust Lawsuit Against Takeda and TWi Pharmaceuticals to Proceed
In a recent development, Takeda Pharmaceutical Co. and TWi Pharmaceuticals face a significant legal challenge as a California federal judge ruled that they must contend with most of a proposed antitrust class action. The lawsuit alleges that the companies engaged in a pay-for-delay scheme to postpone the release of a generic version of Takeda’s heartburn…